Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple nudges boost colon cancer screening rates

NCT ID NCT06710509

Prevention Sponsor: Laura Feemster Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether personalized reminders (like texts or emails) could encourage more people to return their at-home stool test kits for colon cancer screening. Over 2,100 adults aged 45 to 75 who had not yet returned their kit took part. The goal was to see if these gentle nudges could improve screening rates and catch cancer earlier.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,106 people

The number who actually took part.

Started

Dec 2024

Finished

Feb 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 45-75 * Have either a mobile phone number or an email address on file with the health system * Included in and non-compliant on the Ascension Colon Cancer Screening Clinical Priority Goal measure. * Have consented to receive electronic communications from the health system * Ascension primary care provider placed an order for stool testing between 60 and 180 days prior to the intervention. * No record of Cologuard stool testing lab results returned within 60 days of the order being placed. Exclusion Criteria: * Patients whose primary care providers are exempted from the campaign by the health system * Patients with a record of having been screened for colorectal cancer through some other method during the time since the initial order for Cologuard stool testing was placed. * Have received a nudge campaign from the Clinical Transformation team in the past 90 days * Patients who have previously opted out of receiving electronic communications from the health system in our message delivery platform (Salesforce)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colon cancer screening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colon cancer screening

Contacts and locations

Locations

  • Ascension Health

    St Louis, Missouri, 63134, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.